+Search query
-Structure paper
Title | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-inflammatory activity. |
---|---|
Journal, issue, pages | Nat Commun, Vol. 14, Issue 1, Page 6626, Year 2023 |
Publish date | Oct 20, 2023 |
![]() | Andras Boeszoermenyi / Léa Bernaleau / Xudong Chen / Felix Kartnig / Min Xie / Haobo Zhang / Sensen Zhang / Maeva Delacrétaz / Anna Koren / Ann-Katrin Hopp / Vojtech Dvorak / Stefan Kubicek / Daniel Aletaha / Maojun Yang / Manuele Rebsamen / Leonhard X Heinz / Giulio Superti-Furga / ![]() ![]() ![]() |
PubMed Abstract | Dysregulation of pathogen-recognition pathways of the innate immune system is associated with multiple autoimmune disorders. Due to the intricacies of the molecular network involved, the ...Dysregulation of pathogen-recognition pathways of the innate immune system is associated with multiple autoimmune disorders. Due to the intricacies of the molecular network involved, the identification of pathway- and disease-specific therapeutics has been challenging. Using a phenotypic assay monitoring the degradation of the immune adapter TASL, we identify feeblin, a chemical entity which inhibits the nucleic acid-sensing TLR7/8 pathway activating IRF5 by disrupting the SLC15A4-TASL adapter module. A high-resolution cryo-EM structure of feeblin with SLC15A4 reveals that the inhibitor binds a lysosomal outward-open conformation incompatible with TASL binding on the cytoplasmic side, leading to degradation of TASL. This mechanism of action exploits a conformational switch and converts a target-binding event into proteostatic regulation of the effector protein TASL, interrupting the TLR7/8-IRF5 signaling pathway and preventing downstream proinflammatory responses. Considering that all components involved have been genetically associated with systemic lupus erythematosus and that feeblin blocks responses in disease-relevant human immune cells from patients, the study represents a proof-of-concept for the development of therapeutics against this disease. |
![]() | ![]() ![]() ![]() |
Methods | EM (single particle) |
Resolution | 2.5 Å |
Structure data | EMDB-36754, PDB-8jzx: |
Chemicals | ![]() ChemComp-NAG: ![]() ChemComp-CLR: ![]() ChemComp-Q09: |
Source |
|
![]() | PROTEIN TRANSPORT/INHIBITOR / endolysosomal transporter / PROTEIN TRANSPORT-INHIBITOR COMPLEX |